Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) in UC induction and maintenance
Risankizumab maintenance of remission in CD
Guselkumab in CD
Etrolizumab vs adalimumab in UC
Etrolizumab for induction & maintenance of remission in UC
Vedolizumab in paediatric IBD
Etrolizumab for maintenance of remission in UC
Lyophilised oral microbiota transplantation for UC
Mirikizumab phase 2 in CD
Steroid exposure and perinatal outcomes